Successful Trading is the art of minimizing long term risk and maximizing capital allocation.
Recent ALLO News
- Allogene Therapeutics Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 08/08/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 08:06:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 08:04:23 PM
- Allogene Therapeutics Reports Second Quarter 2024 Financial Results and Business Update • GlobeNewswire Inc. • 08/07/2024 08:02:54 PM
- Allogene Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update • GlobeNewswire Inc. • 07/31/2024 12:30:00 PM
- Allogene Therapeutics Activates Three Community Cancer Centers as First Sites for the Pivotal Phase 2 ALPHA3 Trial Evaluating Cemacabtagene Ansegedleucel (cema-cel) as First Line (1L) Consolidation Treatment for Patients with Large B-Cell Lymphoma (LBCL) • GlobeNewswire Inc. • 07/01/2024 12:30:00 PM
- Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel (cema-cel), an Allogeneic CAR T Product, as Part of First Line Treatment for Patients with Large B-Cell Lymphoma (LBCL) Likely to Relapse • GlobeNewswire Inc. • 06/20/2024 12:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/18/2024 08:33:50 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 08:10:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:30:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:35:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:34:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:25:40 PM
- Allogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit • GlobeNewswire Inc. • 05/23/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:40:57 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/14/2024 08:38:13 PM
- Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock • GlobeNewswire Inc. • 05/13/2024 08:47:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:03:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:02:19 PM
- Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update • GlobeNewswire Inc. • 05/13/2024 08:01:00 PM
- Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update • GlobeNewswire Inc. • 05/06/2024 12:30:00 PM
- Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma • GlobeNewswire Inc. • 04/26/2024 12:30:00 PM
- Allogene Therapeutics Announces Q2 Investor Conference Participation • GlobeNewswire Inc. • 04/09/2024 12:30:00 PM
- Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update • GlobeNewswire Inc. • 03/14/2024 08:05:00 PM
- Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease • GlobeNewswire Inc. • 03/12/2024 12:30:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM